Table I.
Distribution of patients with endometriosis and patients with a normal pelvis (control group) according to serum estradiol and progesterone levels and phase of the menstrual cycle.
| Endometriosis | ||||
|---|---|---|---|---|
| Variable | Stage I/II (n=14) | Stage III/IV (n=16) | Controls (n=16) | P-valuea |
| Phase of cycle, n (%) | ||||
| Proliferative | 4 (28.6) | 3 (18.8) | 4 (22.2) | |
| Secretory | 10 (71.4) | 13 (81.2) | 12 (66.7) | |
| Estradiol (pg/ml)b | ||||
| Proliferative | 122 (11–164) | 157 (63–169) | 65 (18–144) | 0.55 |
| Secretory | 143 (65–231) | 102 (42–214) | 91 (55–132) | 0.64 |
| Progesterone (ng/ml)b | ||||
| Proliferative | 0.20 (0.16–0.79) | 0.73 (0.20–0.80) | 0.42 (0.21–0.86) | 0.71 |
| Secretory | 6.12 (0.92–13.22) | 1.05 (0.37–9.50) | 4.15 (0.59–9.16) | 0.44 |
a
Kruskall-Wallis
b
Data presented as median (interquartile range).